logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
Tyrosine-protein kinase LCK Inhibitors (IC50, Ki)
Structure
Compound Name
Standard Type
Standard Values (in nM)
StaurosporineIC501.8 [1]
4-Amino-5-(4-Phenoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-7-Yl-CyclopentaneIC502.0 [1]
DasatinibIC500.4 [1], 1.0 [2], 3.0 [3], 4.0 [4]
N-(2-Chloro-6-methylphenyl)-2-[(cyclopropylcarbonyl)amino]-1,3-thiazole-5-carboxamideIC5035.0 [1], 880.0 [2]
5-(4-Phenoxyphenyl)-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidine-4-amineIC501.0 [1], 10.0 [2], 11.0 [3]

References
This online resource may be cited as follows
MLA
"Quest DatabaseTyrosine-protein kinase LCK Inhibitors (IC50, Ki)." AAT Bioquest, Inc.6 Dec2025https://www.aatbio.com/data-sets/tyrosine-protein-kinase-lck-inhibitors-ic50-ki.
APA
AAT Bioquest, Inc. (2025December 6). Quest DatabaseTyrosine-protein kinase LCK Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/tyrosine-protein-kinase-lck-inhibitors-ic50-ki.
BibTeXEndNoteRefMan